GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis
Clinical trial NCT03474042 · COMPLETED
Trial details
- NCT number
- NCT03474042
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-04-10
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.